Variables | Annual cost of operation ($) | Sharing rate (%) | # of HCV averted | Cost-effectiveness ratio HCV ($) | Cost-benefit ratio HCV |
---|---|---|---|---|---|
Post SSF | 97,203 | 69 | 57 | 1,705 | 20.6 |
 |  | (78, 60) | (65, 50) | (1,495, 1,944) | (23.5, 18.1) |
Two SSF | 194,406 | 59 | 109 | 1,784 | 19.7 |
 |  | (67, 52) | (121, 93) | (1,607, 2,090) | (21.9, 16.8) |
Three SSF | 291,609 | 58 | 110 | 2,651 | 13.3 |
 |  | (67, 52) | (121, 94) | (2,410, 3,102) | (14.6, 11.3) |
Four SSF | 388,812 | 58 | 111 | 3,503 | 10 |
 |  | (67, 52) | (122, 94) | (3,187, 4,136) | (11, 8.5) |
Five SSF | 486,015 | 58 | 112 | 4,339 | 8.1 |
 |  | (67, 52) | (123, 95) | (3,951, 5,116) | (8.9, 6.9) |
Six SSF | 583,218 | 57 | 113 | 5,161 | 6.8 |
 |  | (66, 52) | (124, 95) | (4,703, 6,139) | (7.5, 5.7) |
Seven SSF | 680,421 | 57 | 114 | 5,969 | 5.9 |
 |  | (66, 52) | (124, 96) | (5,487, 7,088) | (6.4, 5) |